To exploit the potential benefits of any such treatment and to facilitate decision making for future plans, it is important to identify early indicators of decline.
It also gives practical advice on how to communicate with patients and families, and can serve as a useful reference for clinicians who are engaged in facilitating decision-making for life-sustaining therapies.
In this sense, the proposed model is a main tool for facilitating decision making in some management aspects such as the quantification of total amount of cones annually supplied to nut industry, design of cone harvest programs or the optimal application of seedling felling.
The paper further explores computational BIM algorithms that can manipulate the information to facilitate decision-making for CWM.
An economical proposal of this kind consists of a wireless network that provides data in real time, and therefore facilitates decision-making for builders and project management.
These linguistic labels were chosen to facilitate decision-making for the staff involved in the process, as well as for being the most suitable communication way used by human beings.
The transfer of this knowledge to the clinical routine would facilitate decision-making for the treatment of unruptured aneurysms.
We developed a decision aid (DA) for patients with metastatic non-small cell lung cancer, to be used during oncology consultations, to facilitate decision-making for advanced lung cancer patients.
To provide accurate information to families at the optimal time to facilitate decision-making for important life events (e.g. school choices, deferred or delayed school entry), screening and assessment for developmental disorders (e.g. Autism Spectrum Disorder), and monitoring for less visible medical conditions (e.g. hypertension).
In addition, efforts should be made to identify representative endpoints or to define suitable indicators for facilitating decision-making within the process, e.g. for sorting products according to their risk.
The next section overviews the evidence supporting tocilizumab and abatacept use (in-line with EMA approval) as equivalent treatment options to rituximab in anti-TNF inadequate responders, with the aim of facilitating decision-making on appropriate treatment for individual patients.
